Published in Gene Therapy Weekly, February 15th, 2001
"IGF-I antisense gene therapy has been applied successfully to animal models of glioma, hepatoma, and teratocarcinoma," wrote A. Ly and colleagues, University of Paris. "The antisense strategy has shown that tumor cells transfected with vectors encoding IGF-I antisense RNA lose tumorigenicity, become immunogenic, and are associated with tumor-specific immune response involving CD8+ lymphocytes."
Ly et al. published their study in the journal Life...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.